Aytu BioScience Inc
AYTU
$1.98+0.51%
Delayed · as of Oct 13, 2026, 2:00 PM ET
Mkt cap
$24.15M
EV/Sales
0.13
P/E ratio
N/A
FY2025 Revenue
$66.38M
EPS (9mo ended 2026-03-31)
$-1.42
Gross Margin (FY2025)
69.04%
Profit Margin (FY2025)
-20.43%
Beta
0.28
Div yield
N/A
Sector
Healthcare
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. Revenue was down 18.0% from 2024-06-30 to 2025-06-30. AYTU currently screens at market cap $24.1M.
Use this AYTU research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AYTU income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Aytu BioScience Inc (AYTU) revenue for Jun 30, 2025 was $66.4M. Net income was -$13.6M. Statements: https://lician.com/financials/aytu
Aytu BioScience Inc (AYTU) market capitalization is $24.1M on the latest cached snapshot.
Aytu BioScience Inc (AYTU) cached previous close $1.97; day range $1.96 – $1.98; volume 13,654. Session quote: https://lician.com/quote/aytu
Aytu BioScience Inc (AYTU) latest cached earnings event is "AYTU earnings" on Sep 22, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AYTU filing is 8-K · Sep 22, 2026. Filings: https://lician.com/sec/aytu